⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

Tesamorelin

Published Research

PubMed-indexed studies for Tesamorelin

Research

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.

AIDS (London, England) 2024
View on PubMed →
Research

Advances in the detection of growth hormone releasing hormone synthetic analogs.

Drug testing and analysis 2021
View on PubMed →
Research

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.

Obesity research & clinical practice 2026
View on PubMed →
Research

Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD.

JCI insight 2020
View on PubMed →
Research

Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.

Scientific reports 2021
View on PubMed →
Research

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.

The Journal of clinical endocrinology and metabolism 2010
View on PubMed →

Research-Grade Tesamorelin

YPB.288
Tesamorelin (20mg)
$285.00
View Product →
YPB.279
Tesamorelin (10mg)
$150.00
View Product →

⚠️ For laboratory research only. Not for human use.